GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Jinhai Medical Technology Ltd (HKSE:02225) » Definitions » YoY EBITDA Growth

Jinhai Medical Technology (HKSE:02225) YoY EBITDA Growth : -214.29% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Jinhai Medical Technology YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Jinhai Medical Technology's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -214.29%.

Jinhai Medical Technology's EBITDA per Share for the six months ended in Dec. 2023 was HK$-0.01.


Jinhai Medical Technology YoY EBITDA Growth Historical Data

The historical data trend for Jinhai Medical Technology's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhai Medical Technology YoY EBITDA Growth Chart

Jinhai Medical Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 338.46 22.58 -34.21 - -80.00

Jinhai Medical Technology Semi-Annual Data
Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -63.16 -5.56 - -23.53 -214.29

Jinhai Medical Technology YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Jinhai Medical Technology's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(0.005-0.025)/ | 0.025 |
=-80.00 %

Jinhai Medical Technology's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.008-0.007)/ | 0.007 |
=-214.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jinhai Medical Technology YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Jinhai Medical Technology's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinhai Medical Technology (HKSE:02225) Business Description

Traded in Other Exchanges
N/A
Address
31 Sungei Kadut Avenue, Singapore, SGP, 729660
Jinhai International Group Holdings Ltd is a Singapore-based company engaged in the provision of manpower outsourcing and ancillary services to building and construction contractors in Singapore. It also provides dormitory services, IT services, and construction ancillary services including warehousing services, cleaning services, and building maintenance work in Singapore. It earns a vast majority of its revenues from the Manpower outsourcing and ancillary services segment.
Executives
Liu Lei 2101 Beneficial owner
Chen Guobao 2201 Interest of corporation controlled by you
Full Fortune International Co., Ltd. 2101 Beneficial owner
Jiang Xiahong 2202 Interest of your spouse

Jinhai Medical Technology (HKSE:02225) Headlines

No Headlines